Cite

HARVARD Citation

    Forster, M. et al. (n.d.). 3112 Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer. European journal of cancer. pp. S639-S640. [Online]. 
  
Back to record